Most importantly, the data presented is correlative and only demonstrates a potential relationship between functional outcomes following AIS and increased plasma levels of CD163, which might be a true phenomenon but also unrelated to disease severity and functional outcomes. Here, CD163 is linked to androgen insensitivity syndrome.